Read + Share
Amedeo Smart
Independent Medical Education
Pavord ID, Bel EH, Bourdin A, Chan R, et al. From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases. Allergy 2022;77:778-797.PMID: 34402066
Email
LinkedIn
Facebook
Twitter
Privacy Policy